通信電纜 網(wǎng)絡(luò)設(shè)備 無線通信 云計(jì)算|大數(shù)據(jù) 顯示設(shè)備 存儲(chǔ)設(shè)備 網(wǎng)絡(luò)輔助設(shè)備 信號(hào)傳輸處理 多媒體設(shè)備 廣播系統(tǒng) 智慧城市管理系統(tǒng) 其它智慧基建產(chǎn)品
行業(yè)產(chǎn)品
博研科研試劑網(wǎng)
暫無信息 |
閱讀:307發(fā)布時(shí)間:2014-6-4
Anti-OPG抗體,骨保護(hù)蛋白/護(hù)骨素抗體相關(guān)產(chǎn)品:
Anti-SSTR3 (somatostatin receptor 3) *受體3抗體
Anti-SSTR4(somatostatin receptor 4) *受體4抗體
Anti-SSTR5 (somatostatin receptor 5) *受體5抗體
Anti-STAT1(signal transducers and activators of transcription 1) 信號(hào)轉(zhuǎn)導(dǎo)與轉(zhuǎn)錄激活因子1抗體
Anti-phospho-STAT1(p-Tyr701) 抗磷酸化信號(hào)轉(zhuǎn)導(dǎo)與轉(zhuǎn)錄激活因子1抗體
Anti-STAT2 (signal transducers and activators of transduction2) 信號(hào)轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子2(STAT2)抗體
Anti-STEAP1(Six transmbrane epithelial antigen of the prostate 1) 前列腺跨膜上皮1抗原抗體
Anti-phospho-STAT3(pThr705) 抗磷酸化信號(hào)轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子3抗體
Anti-phospho-STAT(pThr694) 抗磷酸化信號(hào)轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子抗體
Anti-phospho-STAT6(pThr641) 抗磷酸化信號(hào)轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子6抗體
Anti-STAT3 (signal transducers and activators of transduction 3) 信號(hào)轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子3抗體
Anti-STAT4 (signal transducers and activators of transduction 4) 信號(hào)轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子4抗體
Anti-STAT5 (signal transducers and activators of transduction 5) 信號(hào)轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子5(STAT5)抗體
Anti-STAT6 (signal transducers and activators of transduction 6) 信號(hào)轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子6抗體
Anti-Stra8(Stimulated by retinoic acid gene 8) *激活基因8抗體
Anti-OPG抗體,骨保護(hù)蛋白/護(hù)骨素抗體Background: Osteoprotegerin (OPG, or osteoclastogenesis inhibitory factor) is a secretory glycoprotein belonging to TNF receptor superfamily. Acts as decoy receptor for RANKL and thereby neutralizes its function in osteoclastogenesis. Inhibits the activation of osteoclasts and promotes osteoclast apoptosis. Bone homeostasis seems to depend on the local RANKL/OPG ratio. May also play a role in preventing arterial calcification. May act as decoy receptor for TRAIL and protect against apoptosis. TRAIL binding blocks the inhibition of osteoclastogenesis. OPG acts as a soluble factor in the regulation of bone mass and may be beneficial in the treatment of osteoporosis with increased osteoclast activity. OPG consists of 401 amino acids with a molecular weight of 44 kDa as a monomer and 90 kDa as a disulphide-linked dimer
:021 60340850 021 60340830 021 60340820
客服 :372584443 1091953152 827774711
Anti-OPG抗體,骨保護(hù)蛋白/護(hù)骨素抗體別 名 MGC29565; OCIF; OPG; Osteoclastogenesis Inhibitory Factor; TNFRSF 11B; TNFRSF11B; TR 1; TR1; Tumor Necrosis Factor Receptor Superfamily Member 11b; TR11B_HUMAN
商鋪:http://www.3121000.com/st70965/
主營產(chǎn)品:ELISA試劑盒,科研抗體,細(xì)胞株細(xì)胞系,生物試劑,培養(yǎng)基,動(dòng)物血清
智慧城市網(wǎng) 設(shè)計(jì)制作,未經(jīng)允許翻錄必究 .? ? ?
請(qǐng)輸入賬號(hào)
請(qǐng)輸入密碼
請(qǐng)輸驗(yàn)證碼
請(qǐng)輸入你感興趣的產(chǎn)品
請(qǐng)簡單描述您的需求
請(qǐng)選擇省份